A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 20 (1) , 53-58
- https://doi.org/10.1016/0360-3016(91)90137-s
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using rtog study 7916International Journal of Radiation Oncology*Biology*Physics, 1989
- Accelerated split course regimen in the treatment of brain metastasesRadiotherapy and Oncology, 1988
- Different Fractionation Schedules in Radiation Treatment of Cerebral MetastasesActa Radiologica: Oncology, 1986
- The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Radiation therapy of cerebral metastases: a randomized prospective clinical trialInternational Journal of Radiation Oncology*Biology*Physics, 1977
- The optimum schedule for palliative radiotherapy for metastatic brain cancerInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Rapid fractionation technique and re-treatment of cerebral metastases by irradiationCancer, 1974
- Irradiation of Brain MetastasesActa Radiologica: Therapy, Physics, Biology, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958